Clinical Trials
5 trialsNCT06195306 2026-05-20
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT04268134 2026-05-06
ALTA
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT01252290 2016-12-16
Breast Cancer Risk Biomarkers in Postmenopausal Women
University of Kansas Medical Center
Phase 2 Completed
NCT01252277 2016-07-21
Breast Cancer Risk Biomarkers in Premenopausal Women
University of Kansas Medical Center
Phase 2 Completed
NCT00930527 2014-07-23
Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors
Columbia University
Phase 2 Terminated